Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36239337)

  • 21. PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy.
    Lee SY; Jung DK; Choi JE; Jin CC; Hong MJ; Do SK; Kang HG; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Park JY
    Sci Rep; 2016 May; 6():25952. PubMed ID: 27181838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC.
    Cheng FJ; Chen CH; Tsai WC; Wang BW; Yu MC; Hsia TC; Wei YL; Hsiao YC; Hu DW; Ho CY; Li TS; Wu CY; Chou WY; Yu YL; Tang CH; Chen CY; Chen CM; Hsu JL; Chen HF; Chen Y; Tu CY; Hung MC; Huang WC
    Oncogene; 2021 Feb; 40(6):1162-1175. PubMed ID: 33335306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway.
    Wu T; Wang MC; Jing L; Liu ZY; Guo H; Liu Y; Bai YY; Cheng YZ; Nan KJ; Liang X
    Drug Des Devel Ther; 2015; 9():6421-31. PubMed ID: 26715839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crizotinib vs platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer with different ROS1 fusion variants.
    Xu H; Zhang Q; Liang L; Li J; Liu Z; Li W; Yang L; Yang G; Xu F; Ying J; Zhang S; Wang Y
    Cancer Med; 2020 May; 9(10):3328-3336. PubMed ID: 32168429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways.
    Li C; Dong Y; Wang L; Xu G; Yang Q; Tang X; Qiao Y; Cong Z
    Biochem Cell Biol; 2019 Aug; 97(4):406-414. PubMed ID: 30475650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ad-apoptin inhibits glycolysis, migration and invasion in lung cancer cells targeting AMPK/mTOR signaling pathway.
    Song G; Fang J; Shang C; Li Y; Zhu Y; Xiu Z; Sun L; Jin N; Li X
    Exp Cell Res; 2021 Dec; 409(2):112926. PubMed ID: 34793774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.
    Brock SE; Rendon BE; Yaddanapudi K; Mitchell RA
    J Biol Chem; 2012 Nov; 287(45):37917-25. PubMed ID: 22988252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.
    You J; Cheng J; Yu B; Duan C; Peng J
    Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer.
    Li Q; Yang J; Yu Q; Wu H; Liu B; Xiong H; Hu G; Zhao J; Yuan X; Liao Z
    Clin Cancer Res; 2013 Nov; 19(22):6252-60. PubMed ID: 24077347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
    Zhu J; Ao H; Liu M; Cao K; Ma J
    J Transl Med; 2021 Aug; 19(1):374. PubMed ID: 34461934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.
    Groenendijk FH; Mellema WW; van der Burg E; Schut E; Hauptmann M; Horlings HM; Willems SM; van den Heuvel MM; Jonkers J; Smit EF; Bernards R
    Int J Cancer; 2015 Mar; 136(6):1434-44. PubMed ID: 25080865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.
    Liu M; Jiang L; Fu X; Wang W; Ma J; Tian T; Nan K; Liang X
    Cancer Sci; 2018 Oct; 109(10):3055-3067. PubMed ID: 30033530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence and prognostic value of KRAS co-mutation subtypes in Chinese advanced non-small cell lung cancer patients.
    Cai D; Hu C; Li L; Deng S; Yang J; Han-Zhang H; Li M
    Cancer Med; 2020 Jan; 9(1):84-93. PubMed ID: 31709742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
    Do SK; Jeong JY; Lee SY; Choi JE; Hong MJ; Kang HG; Lee WK; Seok Y; Lee EB; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Neugent ML; Goodwin J; Kim JW; Park JY
    Ann Surg Oncol; 2018 Oct; 25(11):3396-3403. PubMed ID: 30062472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3/AMPK/mTOR/HIF-1α axis.
    Zhang J; Han L; Yu J; Li H; Li Q
    Aging (Albany NY); 2021 Apr; 13(7):10431-10449. PubMed ID: 33819917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial.
    de Fraipont F; Levallet G; Creveuil C; Bergot E; Beau-Faller M; Mounawar M; Richard N; Antoine M; Rouquette I; Favrot MC; Debieuvre D; Braun D; Westeel V; Quoix E; Brambilla E; Hainaut P; Moro-Sibilot D; Morin F; Milleron B; Zalcman G;
    Clin Cancer Res; 2012 May; 18(10):2976-86. PubMed ID: 22434665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer.
    López-Plana A; Fernández-Nogueira P; Muñoz-Guardiola P; Solé-Sánchez S; Megías-Roda E; Pérez-Montoyo H; Jauregui P; Yeste-Velasco M; Gómez-Ferreria M; Erazo T; Ametller E; Recalde-Percaz L; Moragas-Garcia N; Noguera-Castells A; Mancino M; Morán T; Nadal E; Alfón J; Domènech C; Gascon P; Lizcano JM; Fuster G; Bragado P
    Int J Cancer; 2020 Aug; 147(4):1163-1179. PubMed ID: 31943158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Variants in One-Carbon Metabolism Pathway Predict Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer.
    Do SK; Choi SH; Lee SY; Choi JE; Kang HG; Hong MJ; Kim JH; Baek SA; Lee JH; Lee WK; Do YW; Lee EB; Shin KM; Jeong JY; Lee YH; Seo H; Yoo SS; Lee J; Cha SI; Kim CH; Seok Y; Cho S; Jheon S; Park JY
    Oncology; 2020; 98(12):897-904. PubMed ID: 32791502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
    PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.